These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Peripherally acting opioids and clinical implications for pain control. Sehgal N; Smith HS; Manchikanti L Pain Physician; 2011; 14(3):249-58. PubMed ID: 21587328 [TBL] [Abstract][Full Text] [Related]
4. Preclinical studies of opioids and opioid antagonists on gastrointestinal function. Greenwood-Van Meerveld B; Gardner CJ; Little PJ; Hicks GA; Dehaven-Hudkins DL Neurogastroenterol Motil; 2004 Oct; 16 Suppl 2():46-53. PubMed ID: 15357851 [TBL] [Abstract][Full Text] [Related]
5. Opioids and the skin: "itchy" perspectives beyond analgesia and abuse. Schmelz M; Paus R J Invest Dermatol; 2007 Jun; 127(6):1287-9. PubMed ID: 17502859 [TBL] [Abstract][Full Text] [Related]
6. [Treatment of constipation in chronic pain patients]. Shimoyama N; Shimoyama M Masui; 2013 Jul; 62(7):822-8. PubMed ID: 23905405 [TBL] [Abstract][Full Text] [Related]
7. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone). Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626 [TBL] [Abstract][Full Text] [Related]
8. The analgesic actions of centrally administered celecoxib are mediated by endogenous opioids. Rezende RM; Dos Reis WG; Duarte ID; Lima PP; Bakhle YS; de Francischi JN Pain; 2009 Mar; 142(1-2):94-100. PubMed ID: 19186002 [TBL] [Abstract][Full Text] [Related]
9. [Neurochemical analysis and pharmacological regulation of the corticofugal control of the nociceptive signals in the afferent pathways]. Churiukanov VV Eksp Klin Farmakol; 2003; 66(2):24-31. PubMed ID: 12962044 [TBL] [Abstract][Full Text] [Related]
13. Peripheral mu-, kappa- and delta-opioid receptors mediate the hypoalgesic effect of celecoxib in a rat model of thermal hyperalgesia. Correa JD; Paiva-Lima P; Rezende RM; Dos Reis WG; Ferreira-Alves DL; Bakhle YS; Francischi JN Life Sci; 2010 Jun; 86(25-26):951-6. PubMed ID: 20451533 [TBL] [Abstract][Full Text] [Related]
14. Peripherally acting mu-opioid receptor antagonists and postoperative ileus: mechanisms of action and clinical applicability. Viscusi ER; Gan TJ; Leslie JB; Foss JF; Talon MD; Du W; Owens G Anesth Analg; 2009 Jun; 108(6):1811-22. PubMed ID: 19448206 [TBL] [Abstract][Full Text] [Related]
15. Opioids and opioid receptors mediating antinociception at various levels of the neuraxis. Herz A; Millan MJ Physiol Bohemoslov; 1990; 39(5):395-401. PubMed ID: 1965232 [TBL] [Abstract][Full Text] [Related]
16. Nociception increases during opioid infusion in opioid receptor triple knock-out mice. Juni A; Klein G; Pintar JE; Kest B Neuroscience; 2007 Jun; 147(2):439-44. PubMed ID: 17544222 [TBL] [Abstract][Full Text] [Related]
17. Perspectives on opioid tolerance from basic research: behavioural studies after spinal administration in rodents. Stevens CW Cancer Surv; 1994; 21():25-47. PubMed ID: 8564997 [TBL] [Abstract][Full Text] [Related]
18. Blocking mu opioid receptors in the spinal cord prevents the analgesic action by subsequent systemic opioids. Chen SR; Pan HL Brain Res; 2006 Apr; 1081(1):119-25. PubMed ID: 16499888 [TBL] [Abstract][Full Text] [Related]
19. Celecoxib induces tolerance in a model of peripheral inflammatory pain in rats. Rezende RM; Paiva-Lima P; Dos Reis WG; Camêlo VM; Bakhle YS; de Francischi JN Neuropharmacology; 2010 Nov; 59(6):551-7. PubMed ID: 20691196 [TBL] [Abstract][Full Text] [Related]
20. Intravenous ketorolac and subarachnoid opioid analgesia in the management of acute postoperative pain. Gwirtz KH; Kim HC; Nagy DJ; Young JV; Byers RS; Kovach DA; Li W Reg Anesth; 1995; 20(5):395-401. PubMed ID: 8519716 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]